[Treatment of obesity with chorionic gonadotropins. Relations between obesity, dyslipidemia and arthero-arteriosclerosis].
A long account of the many factors responsible form atherosclerosis (dysmetabolism, physical, genetic and familial factors, immunobiological features, diet) is followed by an assessment of obesity as a main risk factor in the local pathology of atherosclerosis. Results obtained in the treatment of obesity with chorionic gonadotropin and a 500 calorie standard diet are presented. These were highly satisfactory with respect to weight loss, tolerance, and marked improvement (or even normalisation) of blood lipid values, which were initially pathological in many cases.
D000328:Adult; D001161:Arteriosclerosis / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004041:Dietary Fats / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000178:diet therapy / Q000188:drug therapy*; D013963:Thyroid Hormones / Q000627:therapeutic use
D006063:Chorionic Gonadotropin; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D008055:Lipids; D013963:Thyroid Hormones; D002784:Cholesterol
Terapia dell'obesità con gonadotropina corionica. Correlazioni tra obesità turbe dislipidemiche e atero-arteriosclerosi